Overall Survival in Advanced Stage Mantle Cell Lymphoma after Early Autologous Stem Cell Transplantation with Cisplatin, Etoposide ,Cytarabine and Melphalan (PEAM) As a Conditioning Regimen

被引：0
作者：
Franco, Daniel [1 ]
Tellez, Fernando [1 ]
Solis-Armenta, Ruben [1 ]
Leal Alanis, Araceli [1 ]
Cruz Castillo, Carlos [2 ]
Valero Saldana, Luis Manuel [1 ]
Acosta Maldonado, Brenda Lizeth [2 ]
机构：
[1] Inst Nacl Cancerol, Mexico City, DF, Mexico
[2] Inst Natl Cancerol, Dept Hematol, Mexico City, DF, Mexico
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-191183
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Comparable safety profile of BeEAM (bendamustine, etoposide, cytarabine, melphalan) and BEAM (carmustine, etoposide, cytarabine, melphalan) as conditioning before autologous haematopoietic cell transplantation
    Frankiewicz, Andrzej
    Sadus-Wojciechowska, Maria
    Najda, Jacek
    Czerw, Tomasz
    Mendrek, Wlodzimierz
    Sobczyk-Kruszelnicka, Malgorzata
    Soska, Katarzyna
    Ociepa, Malgorzata
    Holowiecki, Jerzy
    Giebel, Sebastian
    [J]. WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2018, 22 (02): : 113 - 117
  • [32] Modified BEAM as a conditioning regimen for mantle cell lymphoma patients undergoing autologous hematopoietic stem cell transplantation
    Galieni, Piero
    Falcioni, Sadia
    Troiani, Emanuela
    Picardi, Paola
    Bigazzi, Catia
    Maravalle, Denise
    De Giorgi, Federica
    Taborro, Roberta
    Angelini, Stefano
    [J]. THERAPEUTIC ADVANCES IN HEMATOLOGY, 2024, 15
  • [33] BUSULPHAN-MELPHALAN VERSUS CARBOPLATIN-ETOPOSIDE-MELPHALAN CONDITIONING REGIMEN IN CHILDREN WITH NEUROBLASTOMA UNDERWENT AUTOLOGOUS STEM CELL TRANSPLANTATION
    Atas, E.
    Kesik, V.
    Babacan, O.
    Korkmazer, N.
    [J]. BONE MARROW TRANSPLANTATION, 2014, 49 : S206 - S206
  • [34] Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma
    Herrmann, Annina
    Hoster, Eva
    Zwingers, Thomas
    Brittinger, Guenter
    Engelhard, Marianne
    Meusers, Peter
    Reiser, Marcel
    Forstpointner, Roswitha
    Metzner, Bernd
    Peter, Norma
    Woermann, Bernhard
    Truemper, Lorenz
    Pfreundschuh, Michael
    Einsele, Hermann
    Hiddemann, Wolfgang
    Unterhalt, Michael
    Dreyling, Martin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (04) : 511 - 518
  • [35] LOMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN (LEAM) PROTOCOL AS CONDITIONING REGIMEN BEFORE AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (ASCT) IN PATIENTS WITH LYMPHOMAS: A SINGLE CENTER EXPERIENCE
    Prka, Zeljko
    Vuk, Anamarija Vrkljan
    Cicic, David
    Soric, Ena
    Mitrovic, Zdravko
    Lucijanic, Marko
    Cikara, Marija Ivic
    Jonjic, Zeljko
    Pirsic, Mario
    Pejsa, Vlatko
    Jaksic, Ozren
    [J]. BONE MARROW TRANSPLANTATION, 2024, 59 : 267 - 268
  • [36] Single-center retrospective study assessing the efficacy and safety of BeEAM (bendamustine, etoposide, cytarabine, melphalan) as conditioning regimen for autologous hematopoietic stem cell transplantation
    Plante, Marie-Elaine
    Feng, Xue
    Boudreault, Jean-Samuel
    [J]. LEUKEMIA & LYMPHOMA, 2023, 64 (07) : 1234 - 1242
  • [37] Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle cell lymphoma.
    Joao, C
    Porrata, LF
    Inwards, DJ
    Ansell, SM
    Micallef, INM
    Johnston, PB
    Gastineau, DA
    Markovic, SN
    [J]. BLOOD, 2005, 106 (11) : 454B - 454B
  • [38] Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma
    Joao, C
    Porrata, LF
    Inwards, DJ
    Ansell, SM
    Micallef, IN
    Johnston, PB
    Gastineau, DA
    Markovic, SN
    [J]. BONE MARROW TRANSPLANTATION, 2006, 37 (09) : 865 - 871
  • [39] Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma
    C Joao
    L F Porrata
    D J Inwards
    S M Ansell
    I N Micallef
    P B Johnston
    D A Gastineau
    S N Markovic
    [J]. Bone Marrow Transplantation, 2006, 37 : 865 - 871
  • [40] EAM (ETOPOSIDE, CYTARABINE, MELPHALAN) BEFORE AUTOLOGOUS STEM CELL TRANSPLANTATION IS SAFE AND EFFECTIVE FOR RESISTANT/RELAPSED HODGKIN LYMPHOMA PATIENTS
    Bekadja, A.
    Bouhass, R.
    Osmani, S.
    Brahimi, M.
    Talhi, S.
    Yafour, N.
    Arabi, A.
    [J]. HAEMATOLOGICA, 2015, 100 : 791 - 791
12345